| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.052 | 0.08 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.08 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.08 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.08 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.08 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.08 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |